Article
Nanoparticle-Conjugated TLR9 Agonists Improve the Potency, Durability, and Breadth of…
medRxiv · 2023 · Ben S. Ou
Key facts
| Title | Nanoparticle-Conjugated TLR9 Agonists Improve the Potency, Durability, and Breadth of COVID-19 Vaccines |
|---|---|
| First author | Ben S. Ou |
| Journal | medRxiv |
| Published | Oct 12, 2023 |
| DOI | 10.1101/2023.01.02.522505 |
| Devices mentioned | K790117, K802418, K822496 |
| Product codes mentioned | JIT, JXR, KIS |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1